Johnson & Johnson’s 1Q Sales Drop 4.1 Percent

By Staff
Wednesday, April 15, 2015 12:23 AM NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) announced sales of $17.4 billion for the first quarter of 2015, a decrease of 4.1 percent compared to the first quarter of 2014.

GlassesUSA.com Closes on $12.5 Million to Expand Globally

By Staff
Wednesday, April 01, 2015 12:30 AM TEL-AVIV—Online optical retailer, GlassesUSA.com has closed on $12.5 million in new financing led by Viola Private Equity, a member of the Viola Group. The funding will be used toward accelerating the company’s expansion in the growing global online eyewear market, both business-to-consumer and business-to-business.

New Look Posts Record Revenues for Both 4Q and Year-End

By Staff
Wednesday, March 18, 2015 12:29 AM MONTREAL, Quebec— New Look Eyewear Inc. (BCI.TO), based here, posted record revenues for both the fourth quarter and year ended Dec. 27, 2014.

The Cooper Companies Stockholders Elect Eight Directors

By Staff
Wednesday, March 18, 2015 12:26 AM

Actavis and Allergan Shareholders Approve Proposals Related to Actavis’ Planned Acquisition of Allergan

By Staff
Friday, March 13, 2015 12:20 AM DUBLIN, Ireland & IRVINE, Calif.— Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) announced at a shareholder meetings held this week that all proposals related to Actavis’ planned acquisition of Allergan were approved by both Actavis’ and Allergan’s shareholders.

The Cooper Cos. Reports Increase in Revenues for Q1, Including Gains for CooperVision

By Staff
Friday, March 06, 2015 12:26 AM PLEASANTON, Calif.—The Cooper Companies, Inc. (NYSE:COO) announced financial results for the fiscal first quarter ended Jan. 31, 2015. For the period, overall revenue rose 10 percent to $445.2 million.

Safilo Group Reports Sales and Profit Increase for Year End 2014 Results

By Staff
Friday, March 06, 2015 12:23 AM PADUA, Italy—The board of directors of Safilo Group S.p.A. (SFLG.MI) has approved the company’s consolidated financial results for the fourth quarter and the year ended Dec. 31, 2014.

SPY Inc. Issues Q4 and Year-End 2014 Results

By Staff
Friday, March 06, 2015 12:20 AM CARLSBAD, Calif.— SPY Inc. (OTCBB: XSPY) announced financial results for the year ended Dec. 31, 2014.

North America Helped Drive Record Year for Luxottica in FY 2014

By Staff
Wednesday, March 04, 2015 12:25 AM MILAN— Luxottica Group (NYSE: LUX) reported record net sales and profits for fiscal year ending Dec. 31, 2014.

Nikon Agrees to Buy Optos for $400 Million Cash

By Staff
Friday, February 27, 2015 9:05 AM NEW YORK— Nikon (T:7731) has agreed to buy Optos (L:OPTS), the British retinal imaging company for £259.3 million, or $400 million in cash.

Essilor Reports 15.4 Percent Rise in Operating Profit in FY 2014

By Staff
Friday, February 20, 2015 12:25 AM CHARENTON-LE-PONT, France— Essilor International (Reuters: ESSI.PA) reported a 15.4 percent increase in operating profit for the year ending December 31, 2014, along with a 12 percent rise in revenue.

Unilens Reports Improved Sales, Revenues and Profits for Q2 and First Half of Fiscal Year 2015

By Staff
Wednesday, February 18, 2015 12:23 AM LARGO, Fla.— Unilens Vision Inc. (OTCQX: UVIC) reported financial results for the second quarter and first half of fiscal year 2015, which ended Dec. 31, 2014, for the contact lens supplier.

Allergan Reports 13.8 Percent Sales Increase in Q4 2014

By Staff
Friday, February 06, 2015 12:23 AM IRVINE, Calif.— Allergan, Inc. (NYSE: AGN) reported total product net sales of $1,889.0 million for the quarter ended Dec. 31, 2014, an increase of 13.8 percent increase, or 17.2 percent on a constant currency basis, compared to total product net sales in the fourth quarter of 2013.

Eyeglass Lenses Drive Hoya’s 3Q 2014 Profits

By Staff
Monday, February 02, 2015 12:26 AM TOKYO— Hoya Corp. (TOKYO: 7741) reported gains in revenue and profit for the third quarter ended Dec. 31, 2014.

Presbia Announces Pricing of Initial Public Offering

By Staff
Monday, February 02, 2015 12:23 AM IRVINE, Calif.— Presbia PLC, an ophthalmic device company that has developed and is currently marketing the Presbia Flexivue Microlens, a proprietary optical lens implant for treating presbyopia, announced the pricing of its initial public offering of 4,166,667 ordinary shares at a public offering price of $10.00 per share, before underwriting discounts. All of the ordinary shares are being offered by Presbia.
Loading...